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Nonsegmented negative-stranded (NNS) RNA viruses, among them
the virus that causes rabies (RABV), include many deadly human
pathogens. The large polymerase (L) proteins of NNS RNA viruses
carry all of the enzymatic functions required for viral messenger RNA
(mRNA) transcription and replication: RNA polymerization, mRNA cap-
ping, and cap methylation. We describe here a complete structure of
RABV L bound with its phosphoprotein cofactor (P), determined by
electron cryo-microscopy at 3.3 Å resolution. The complex closely
resembles the vesicular stomatitis virus (VSV) L-P, the one other
known full-length NNS-RNA L-protein structure, with key local
differences (e.g., in L-P interactions). Like the VSV L-P structure,
the RABV complex analyzed here represents a preinitiation con-
formation. Comparison with the likely elongation state, seen in
two structures of pneumovirus L-P complexes, suggests differences
between priming/initiation and elongation complexes. Analysis of
internal cavities within RABV L suggests distinct template and prod-
uct entry and exit pathways during transcription and replication.
rabies lyssavirus | NNS RNA viruses | vesicular stomatitis virus |
transcription | replication
Rabies virus (RABV) and other viruses with nonsegmented,negative-strand (NNS) RNA genomes have, as the catalytic
core of their replication machinery, a large, multifunctional RNA
polymerase (L). Many of these viruses are serious human patho-
gens, including Ebola virus, respiratory syncytial virus, and mea-
sles. Vaccines are available for some, including descendants of the
storied work on rabies by Louis Pasteur and Pierre Paul Émile
Roux, but specific, small-molecule therapeutics are still under
development. By analogy with inhibitors of viral polymerases of
many other types, L would be a suitable candidate for inhibitor
development, for which structural and mechanistic studies are
essential precursors.
For all mononegaviruses, including the rhabdoviruses RABV
and vesicular stomatitis virus (VSV), L associates with a cofactor
known as P (for phosphoprotein). P bridges L with the viral
nucleocapsid, an antisense RNA genome fully encapsidated by
the viral nucleoprotein (N). The complete structure of L from
VSV (1), the sole example published so far of an NNS viral
polymerase in which all five domains are clearly resolved, shows
the global features that sequence comparisons suggest it has in
common with most other NNS RNA viral L proteins. Its multi-
domain organization includes three enzymatic modules: an RNA-
dependent RNA polymerase (RdRp), a capping domain (CAP),
and a dual-specificity methyltransferase (MT) domain. CAP is a
GDP:polyribonucleotidyltransferase (PRNTase) that transfers a 5′
monophosphate of the nascent RNA transcript onto a GDP
acceptor (2); the single MT domain methylates the ribose 2′-O
position on the first nucleotide of the transcript and then the
N-7 position of the capping guanylate (3). Transcription initi-
ation and cap addition require several residues within or
proximal to a priming loop from CAP, which extends into the
RdRp core (4). Residues at related positions in the RABV L
amino acid sequence are similarly essential for its activities. A
connector domain (CD) and a C-terminal domain (CTD), both
with nonenzymatic functions, flank the MT domain and, in
conjunction with P, likely facilitate the large structural rearrange-
ments that appear to coordinate the three enzymatic activities
during transcription and replication.
We report here an atomic model of L from RABV SAD-B19
in complex with a 91-residue, N-terminal fragment of P (P1–91)
from electron cryo-microscopy (cryo-EM) at an average reso-
lution of 3.3 Å. The atomic structure resembles that of VSV
L-P in many respects, consistent with the 34.1% amino acid
sequence conservation between the two L proteins. As in the
VSV L-P complex, binding of P1–91 locks the CD, MT domain,
and CTD into a fixed, “closed” arrangement with respect to the
large RdRp-CAP module. This closed conformation appears to
represent the L protein poised for initiation at the 3′ end of the
genome or antigenome. Comparison with structures of two
recently published pneumovirus L-P complexes (5, 6) as well
as with that of a VSV L-P reconstruction determined at 3.0 Å
resolution (7) suggests that replication and transcription have
alternative priming configurations and alternative product exit
sites.
Significance
Rabies virus (RABV) and other viruses with single-segment,
negative-sense, RNA genomes have a multi-functional polymer-
ase protein (L) that carries out the various reactions required for
transcription and replication. Many of these viruses are serious
human pathogens, and L is a potential target for antiviral ther-
apeutics. Drugs that inhibit polymerases of HCV and HIV-1 pro-
vide successful precedents. The structure described here of the
RABV L protein in complex with its P-protein cofactor shows a
conformation poised for initiation of transcription or replication.
Channels in the molecule and the relative positions of catalytic
sites suggest that L couples a distinctive capping reaction with
priming and initiation of transcription, and that replication and
transcription have different priming configurations and different
product exit sites.
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Identification of a Stable L-P Complex. We have determined pre-
viously that a minimal fragment of the N-terminal domain of
RABV P, P11–50, is sufficient to stimulate processivity of RABV
L on a nonencapsidated RNA template derived from the 3′
leader sequence of the RABV genome (8). In our prior studies
of VSV, we found a minimal fragment of VSV P that stimulated
VSV L activity in vitro and also stably anchored its C-terminal
globular domains (CD, MT, and CTD) against the N-terminal
RdRp and CAP domains (9, 10). We visualized RABV L alone
or in complex with various fragments of P by negative-stain
electron microscopy (Fig. 1) and found that, in the absence of
P, the C-terminal domains of RABV L, like those of VSV L,
have a range of positions with respect to the ring-like RdRp-CAP
core (Fig. 1B). While P11–50 stabilized the C-terminal domains of
RABV L, a longer fragment (P1–91) shifted their positions further,
to a degree equivalent to that achieved by adding full-length P
(PFL) (Fig. 1C). To fit the structure of VSV L (obtained in com-
plex with VSV P35–106) into a low-resolution map for RABV L-
P11–50, we needed to fit the C-terminal domains at an ∼80° offset
(data not shown), but we could readily fit the low-resolution maps
of RABV L-P1–91 and RABV L-PFL with the structure of VSV L
as a single rigid body (Fig. 1 C, Right). We inferred that the RABV
L-P1–91 and VSV L-P35–106 complexes reflected analogous states
and therefore used P1–91 to determine the RABV L structure
by cryo-EM.
Cryo-EM Structure Determination. We immobilized purified com-
plexes of RABV L-P1–91 in vitreous ice and visualized them by
cryo-EM (SI Appendix, Fig. S1 A and B) as described in Materials
and Methods. We created an initial three-dimensional (3D) refer-
ence de novo using the ab-initio module in cisTEM (11) from dose-
fractionated movies obtained at 200 kV acceleration and calcu-
lated a 6.7 Å resolution map from 22,000 particles after classifi-
cation and refinement using RELION (12) (SI Appendix, Fig.
S1C). In extending the resolution from movies recorded at 300 kV
acceleration, preferred orientation of the particles in the ice
complicated particle selection and 3D reconstruction. By using an
angular binning procedure to decrease representation of common
views (SI Appendix, Figs. S1D and S2), we obtained a reasonably
isotropic reconstruction using cisTEM. After per-particle, projection-
based contrast transfer function (CTF) and motion correction
(Bayesian polishing) in RELION 3.0 (13, 14), refinement in cisTEM
yielded a map with an average resolution of 3.3 Å (Fourier shell
correlation = 0.143 criterion; Fig. 2A and SI Appendix, Figs.
S1E and S2).
To generate an atomic model, we aligned and threaded the
sequence of RABV L onto the atomic coordinates of VSV L and
crudely fit the model to the map using Rosetta (15–17). After
manual adjustment, we could fit nearly all of the 2,127-residue
polypeptide chain of L from residue 29 to the C terminus (Fig. 2).
We assigned residues for regions of continuous, but disordered,
density in the CAP priming loop (1,177 to 1,184) and the long
Fig. 1. Effect of P on conformation of L. (A) Electron micrograph of negatively stained RABV L. (Scale bar, 25 nm.) (B) Representative 2D class averages of L alone
or in complex with P11–50. (Scale bar, 5 nm.) Arrowheads indicate flexible conformations of the three C-terminal globular domains of L. (C) Three-dimensional
reconstructions of negatively stained L alone or in complex with the indicated fragment of P. Red dashed circle indicates poor density for the disordered C-terminal
globular domains in the absence of any P. (Right) The VSV L atomic model fit into the RABV L-PFL reconstruction.



















































linker between the CD and MT domains (1,624 to 1,635) because
there was little ambiguity about the general course of the poly-
peptide chain, although the Cα positions and the side-chain
orientations are imprecise. Several interdomain linkers that
were ambiguous in the VSV L map have continuous and ordered
density for the analogous regions in the RABV L map, permitting
assignment of their residues with high confidence. The clarity of
side-chains throughout all five domains of L indicates that regions
of the map with poor density reflect local flexibility rather than
wholesale domain movements (SI Appendix, Fig. S3). Domain-
specific refinement from a much larger portion of the dataset
using RELION Multi-Body showed significant interdomain flexi-
bility (Movie S1) and suggested that the comparatively small
fraction of the dataset used for the 3.3-Å reconstruction reflects a
particular configuration within a somewhat broader ensemble.
Rigorous selection of this small set of homogeneous particles
for the 3.3-Å map yielded clear and nearly continuous density for
the C-terminal half of P1–91. Visible density for some side-chains
on a stretch of P bound to the CTD permitted assignment of the
sequence register in this region, from which we have inferred the
approximate residue positions for the remainder of visible P
density. We have therefore assigned 37 of the 91 residues of P
included in the complex (Fig. 2 C and D), not including a stretch
of 5 residues, which we could not assign, bound to the top of the
CTD. The cryo-EM data collection and model validation statis-
tics for the map and complete RABV L-P structure are sum-
marized in SI Appendix, Table S1.
The structures of RABV and VSV L in complex with their
respective P fragments are very similar (Fig. 2C). Rigid-body align-
ment of these structures yields a root-mean-square deviation (rmsd)
of 1.905 Å based on 1,539 Cα residues; individual domain rmsds are
0.91 Å (595 Cα), 1.07 Å (352 Cα), 2.09 Å (186 Cα), 1.50 Å (233 Cα),
and 3.68 Å (120 Cα), respectively, for the RdRp, CAP, CD,
MT, and CTD domains superposed independently (SI Appendix,
Fig. S4). There is nearly complete conservation of the secondary
structure elements from end to end, owing to strong sequence
conservation between each of the five domains for both proteins:
shared amino acid identities are 36.1, 41.9, 25.4, 31.2, and 20.1%
for the RdRp, CAP, CD, MT, and CTD domains, respectively. The
overall course of P as it transits through L is also similar for both
RABV and VSV, despite broad differences in sequence among
the residues that could be assigned for the respective P fragments
and the mere 11.8% shared amino acid identities between them
overall.
Phosphoprotein Fragment P1–91.We detect two segments of density
for the P1–91 polypeptide chain (Fig. 3). One segment binds in a
groove on the outward-facing surface of the CTD above the C-
terminal residues of L (Fig. 3 A, i). This segment is too short to
assign its sequence with confidence, but biochemical experiments
that measured RABV L processivity on naked RNA templates in
the presence of N-terminal fragments of P suggest that this in-
teraction involves at least some of the residues immediately fol-
lowing Gln40 of P (8). The second segment is much longer, with a
continuous stretch of 37 residues. It contains about 11 residues
bound on the proximal face of the CTD, probably in part through
a salt bridge between Glu51P and Arg2039L (Fig. 3 A, ii); about 3
residues in contact with a long RdRp helix (residues 746 to 773),
probably including a salt bridge between Asp60P and Arg754L
(Fig. 3 A, iii); and about 13 additional residues in the groove be-
tween the RdRp and CD (Fig. 3 A, iv). The C terminus of the
ordered segment that we could build is Glu87P. The closer asso-
ciation of P with the proximal face of the CTD of L for RABV
relative to VSV suggests that RABV P partially compensates for
the C-terminal tail that is “missing” in RABV L (Fig. 3B).
As a first check on the polarity that we had assigned to P, we
fused GFP to the N terminus of P1–91 and visualized its complex
with L by negative-stain EM (Fig. 4A). A low-resolution 3D
Fig. 2. Structure of the RABV L-P complex. (A) A 3.3-Å cryo-EMmap of RABV L-P1–91 andmodel fit into the density with clear side-chains even on exterior residues.
(B) Domain organization of RABV L, with key catalytic residues listed. Numbers give amino acid positions at domain boundaries. (Below) Locations of conserved
regions (CRI-VI) throughout NNS RNA virus L proteins and amino acid similarity score with VSV L (Indiana strain); black lines indicate identical residues (∼35%). (C)
Structure of RABV L-P1–91 (Left) and the model of VSV L-P35–106 from a 3.0-Å cryo-EM map (Right) (7). Domains are colored as in B. P for both structures is shown in
surface representation, colored in plum (RABV) and light pink (VSV). The five unassigned residues of RABV P are represented in plum ribbon. (D) Domain or-
ganization of RABV P (Top) amino acid positions (red asterisk, position of Ser63P, typically phosphorylated). (Below) Alignment with VSV P (purple lines, modeled
RABV P residues; boldface letters, modeled VSV P residues; asterisks, shared residues; colons, chemically similar residues; periods, weakly similar residues; red,
phosphorylation sites).



























































reconstruction showed diffuse density for the globular GFP at the
top of L, radiating from a position near the top of the long CD:MT
linker (Fig. 4A and SI Appendix, Figs. S5 and S6). This result is
consistent with our assignment of the direction of P residues in
the density and with our assignment of residues near Gln40P to
the segment bound on the CTD outward-facing surface. The
map for the L-GFP-P1–91 complex otherwise resembled that of
the L-P1–91 complex without GFP (SI Appendix, Fig. S6), indi-
cating that N-terminal fusion of GFP to P1–91 had not disrupted
its binding to L.
We confirmed the location of the C terminus of P1–91 by visu-
alizing RABV L in complex with PFL by negative-stain EM, which
showed dimers of RABV L that closely resembled those of VSV L
complexed with full-length VSV P (10). The central, oligomeri-
zation domain of RABV P (POD) includes residues 91 to 133,
which form a homodimer (18). We matched projections of the
high-resolution RABV L-P1–91 map to each L monomer in the
negative-stain EM two-dimensional (2D) class averages (Fig. 4B
and SI Appendix, Figs. S7–S9). The distance between P91 residues
in the crystal structure of the homodimeric RABV POD is 25 Å,
and the last ordered residue in our model is 87, giving a spacing
(assuming a flexible but extended chain for 87 to 91) of about
55 Å for the exit points of P on two L molecules in the L-PFL dimer.
Projection matching of the dimer partners in negative-stain EM
images yielded spacings of ∼60 ± 10 Å, while the distances be-
tween the N termini of the short, bound segment of P varied widely
from 0 to 90 Å (Fig. 4C). We also found several different dimer
arrangements (SI Appendix, Fig. S9), all compatible with the po-
larity of the segments of P that we have modeled, with our as-
signment of the C-terminal residues of P1–91 and with flexibility of P
residues 87 to 91.
RNA-Dependent RNA Polymerase. The RdRp domains of RABV
and VSV L have nearly coincident 3D structures (SI Appendix,
Fig. S4), as expected from their amino acid sequences, which are
identical at 36.1% of the aligned positions. They have the familiar
finger-palm-thumb structure at their core, augmented by a sub-
stantial N-terminal subdomain and by a C-terminal transition into
the capping domain (SI Appendix, Fig. S10). The catalytic site
(GDN motif) is within a central hollow, connected to the exte-
rior of the molecule by four channels. Comparison with double-
stranded RNA virus polymerases, for which structures of initiating
and elongating complexes are known (19, 20), has allowed as-
signment of these channels to the four molecular-passage func-
tions required for RdRp activity: template entry, template exit,
nucleotide substrate entry, and product exit (Fig. 5) (21). In the
initiation-competent configuration of RABV L that we describe
here, the product exit channel is occluded by a retractable priming
loop from CAP (Fig. 5B, discussed below), while the putative
template exit channel appears “closed” by a grouping of small
loops. The exiting template RNA could push these loops aside
during elongation (Fig. 5C), as shown for template exiting from
influenza virus polymerase (22). A substantially more open
channel is present in VSV L (7).
The region with weakest conservation, both of sequence and of
structure, surrounds the template entrance channel, the position
at which the template must separate from N and thread through
the catalytic site. Evidence that virus-specific features of L may
facilitate this process comes from the observation that RABV L
cannot transcribe RNAs from the VSV nucleocapsid, even when
the RNP-binding region of P is replaced by that of VSV (8). The
N-terminal 28 residues of RABV L are disordered, as are the
initial 34 residues of VSV L. Their adjacency to the template
entrance channel suggests a role in nucleocapsid engagement and
Fig. 3. Association of RABV P1–91 with L. (A, Left) RABV L-P1–91 as in Fig. 2C. Bubbled letters indicate the regions shown in greater detail in i–iv on the
Right. (A, Right) (i) Unassigned residues of P at the top of the CTD with the 3.3-Å map in black mesh. (ii–iv) Indicated residues of L (black) and P (purple) in
stick representation. (B) CTDs of RABV and VSV L; P is in plum for RABV and light pink for VSV. Black arrows indicate the C-terminal residues of each L. (C )
Superposition of RABV L (colored cartoon, as in Fig. 2) and VSV L (gray cartoon). (Left) Different paths taken by RABV P (plum, surface) and VSV P (light
pink, surface) through L. (Right) RABV P (plum, surface) is partially coincident with the VSV C-tail (red, surface) in the interdomain cavity of L, while VSV P
occupies far less of the same cavity.



















































template insertion; the low isoelectric point of the disordered
peptide further suggests that it might facilitate separation of
the template RNA from N.
Capping Domain. The RABV L capping enzyme catalyzes the
formation of GTP-capped pre-mRNA by a mechanism that dif-
fers from eukaryotic capping. The nascent RNA transcript with a
5′ triphosphate is first covalently linked to a catalytic histidine
residue (H1241) in a reaction that leads to a monophosphate
RNA-L intermediate. This linkage is subsequently thought to be
attacked by a GTP molecule, resulting in addition of GDP to the
monophosphate-RNA to form a GTP-capped pre-mRNA (23).
Several residues in both RABV and VSV CAP that affect cap
addition have been identified, including the GxxT and HR motifs
broadly conserved throughout Mononegavirales (1, 24). The his-
tidine in the latter motif is the site of covalent attachment. While
we initially supposed that the GxxT motif would support the
substrate GTP, the precise role of the motif in capping is unclear,
as mutation of the threonine, essential for VSV capping (25), is
less critical for capping by RSV L (26). The respective CAP do-
mains are extremely similar (SI Appendix, Figs. S4 and S11), al-
though there are small differences in the positioning of certain
loops, including those in or near the active site (SI Appendix, Fig.
S11A). The two sites that coordinate structural zinc ions in VSV L
are also present in RABV L (SI Appendix, Fig. S11B). Each site
includes two pairs of residues separated by approximately 200
residues in the polypeptide chain, thereby joining separate
regions within the CAP domain.
The GxxT motif leads into the ∼20-residue-long priming loop,
which extends from CAP toward the RdRp active site (SI Ap-
pendix, Fig. S11C), as we also found for VSV L (1). Relatively poor
density in both maps indicates conformational variability. The state
captured in this structure is evidently a preinitiation or initiation
conformation, as elongation after priming requires that the prim-
ing loop withdraw from the RdRp catalytic cavity to make room
for nascent product to reach the CAP active site and extend up-
ward into the MT domain (Fig. 5). The catalytic cavity of CAP
appears to be large enough to accommodate a retracted priming
loop (Fig. 5B), together with a short segment of nascent transcript,
even without displacing CAP from RdRp.
Connector Domain. The RABV CD has no known enzymatic
function and probably has a largely organizational role. The CD
of RABV L consists of eight helices; long linkers at either end
connect it to the CAP and MT domains (SI Appendix, Fig. S12).
Whereas the CAP-CD linker is sufficiently ordered to assign
Fig. 4. Analysis of negatively stained L-GFP-P1–91 and L-P dimers. (A, Left) Two-dimensional class averages of negatively stained L-GFP-P1–91 and matched
projections of the RABV L atomic model with GFP position approximated (SI Appendix, Figs. S5 and S6). (A, Right) GFP trace from a 3D reconstruction of
negatively stained RABV L-GFP-P1–91 (SI Appendix, Fig. S6) superimposed on the RABV L atomic model. (B) Two-dimensional classes of negatively stained RABV
L-PFL dimers and matched projections of the RABV L atomic model (SI Appendix, Figs. S7–S9), as described in legend to SI Appendix, Fig. S7. Square boxes in A
and B are 336 Å on a side. (C) Minimal distances between Cα atoms of either P87 (C:C) or the N terminus of the P segment bound at the CTD apex (N:N) for each
projection-matched dimer. (D) Approximate locations of P1 and P91 with respect to L determined from the projection-matching analysis.



























































rotamers to several larger side-chains, much of the longer CD-MT
linker is disordered, and even main-chain coordinates can be
assigned only approximately. Nevertheless, the general course
of the latter linker is clear, and we have therefore included the
poorly ordered residues in the model (SI Appendix, Fig. S12A).
Opposite the HR motif at the CAP active site are three tightly
grouped basic resides in the final helix of the CD (SI Appendix, Fig.
S12B). The first two, Arg1610 and His1611, conserved among all
Lyssavirus L, are also present in VSV L. The third, R1614, is either
arginine or lysine in all lyssaviruses; it is a lysine in VSV L. The
proximity of these basic residues in the CD to the catalytic HR
motif in CAP, as well as their chemical composition, suggest that
they may help guide the nascent transcript toward His1241, the
position of covalent attachment. Alternatively, they could direct
GTP-capped mRNAs into the MT active site.
Methyltransferase Domain. The RABV MT is likely to be a dual-
function enzyme that methylates the GTP cap of viral mRNAs,
first at the 2′-O and then at the N-7 position, as shown for the
VSV MT (3). The structurally conserved RABV and VSV MT
domains closely resemble other dual-function viral MTases, in-
cluding those of West Nile Virus (WNV), Dengue Virus (DENV)
(SI Appendix, Fig. S13), and human metapneumovirus (27–29).
A shared GxGxG motif forms the binding site for the methyl
donor, S-adenosylmethionine (SAM), and a conserved set of
charged residues (K-D-K-E; RABV residues Lys1685, Asp1797,
Lys1829, and Glu1867) forms the catalytic tetrad for methyl
group addition (30–33). The K-D-K-E tetrads in RABV and
VSV MTs are slightly further from the SAM-binding site than in
WNV and DENV MTs, possibly due to the presence of bound S-
adenosylhomocysteine (modeled) in the WNV and DENV MT
crystals; there is no such density in the RABV and VSV L cryo-
EM maps.
In addition to the K-D-K-E and GxGxG motifs, we identified
neighboring residues in RABV L that are interspersed with the
K-D-K-E residues and are close to the presumptive cap-binding
site [indicated by the location of ribavirin in the DENV MTase
structure (27)]: R1674, Y1831, T1860, and Y1869 (SI Appendix,
Fig. S13B). These residues balance charges of the catalytic res-
idues and may support cap positioning for methylation and/or
reaction order. They are conserved throughout Rhabdoviridae
and match similarly positioned residues in WNV and DENV.
C-Terminal Domain. The CTDs of RABV and VSV L are the least
conserved of the five domains; only 20.1% of the amino acid
residues at corresponding positions are the same. Nonetheless,
direct alignment of the CTDs shows they are close structural
homologs (SI Appendix, Fig. S3) with an rmsd of 3.7 Å.
Density for the CTD was less well defined than it was for most
of the rest of the molecule. Multibody refinement of an expanded
particle dataset showed that both the CTD and the MT explore a
range of conformations, flexing with respect to the other domains
(Movie S1). While the MT flexes as a rigid domain, the CTD
appears to have “open” and “closed” conformations that would
involve remodeling the α helix spanning residues 2,092 to 2,105
(see the upper left in the middle and right panels, Movie S1).
This hinge-like behavior may account for the lack of well-ordered
density for P at the apex of the CTD in the high-resolution map.
Elements of the CTD closest to the MT domain, such as the helix
spanning residues 2,019 to 2,033, follow the MT domain away
from the rest of the CTD when open, consistent with the close
contact between the two sequential domains. The open state in our
particle set could represent a fluctuation toward the fully open
conformational ensemble seen in the absence of P, in which the
CD, MT, and CTD all move away from the RdRp-CAP module.
We suggest below that capping and methylation may require
opening of L in this way.
The C-terminal tail that anchors the CTD in VSV L is absent
in RABV L, which has 24 fewer residues. Whereas the C-terminal
tail in VSV L-P projects into a cavity in the core of the complex
bounded by each of the five domains (Fig. 3 B and C), the C
terminus of RABV L terminates at the surface of the globular
Fig. 5. Proposed RNA transit through L. (A–C) Cutaways showing continuous internal cavities (gray, translucent surface) through L (colored, as in Fig. 2C)
when the priming loop residues (green ribbon) are deleted from the model. Black arrows indicate nucleotide and template entrance channels and the
presumed RNA product exit channel. (B) Cavity into which the priming loop may retract during elongation (white dashed arrow). Nascent RNA may continue
toward the CAP active site (HR motif) following internal initiation for mRNA transcription (solid orange arrow) or directly upward toward the MT domain
following terminal de novo initiation for genomic RNA replication (dashed orange arrow). (C) The presumed template exit channel at the back of the CAP
domain (black dashed circle) is occupied by small loops, which we propose move aside as polymerization progresses.



















































CTD (Fig. 3B). A segment of P that penetrates the gap between
CTD and CD, and somewhat closer packing of the adjacent
domains, together appear to compensate for the “missing”C-terminal
arm (Fig. 3C).
Priming, Initiation, Elongation, and Capping. The structure described
here, together with those of VSV L-P at 3.0 Å resolution (7) and of
two recently published pneumovirus L-P complexes (5, 6), suggests
a mechanism for switching between replication and transcription,
with alternative priming configurations and alternative sites for
product exit.
The “priming loop” (residues 1,170 to 1,186 in the CAP do-
main) projects into the RdRp catalytic cavity, closing off a channel
that connects it with the catalytic cavity of the CAP domain. Model
building in the homologous VSV L-P complex shows that an ini-
tiating nucleotide would stack on a tryptophan (W1167), corre-
sponding to residueW1180 in RABV L, at the tip of the projecting
loop (7). Mutation of this residue compromises end initiation, but
not internal initiation or capping (4). Elongation beyond formation
of the initial dinucleotide requires that the priming loop retract
into the CAP catalytic cavity. The recent pneumovirus L-P struc-
tures show just such a retracted configuration (5, 6). A nascent
transcript can then pass across the retracted loop. Moreover,
analysis of cavities in the L-P complex (Fig. 5) shows that, after
priming loop retraction, a continuous tunnel leads from the con-
nected catalytic cavities of RdRp and CAP to a likely exit site for
the full-length replication products (antigenomic and genomic
RNA). Proximity of this putative exit site to the N-terminal end of
P would then allow prompt delivery of N protein, bound near the
N terminus of P, coating and protecting the emerging replication
product (or uncapped leader transcript).
The N-protein delivery pathway suggested above depends on
the site at the apex of the CTD that anchors the N-terminal
segment of P. That site is a shallow pocket, which accommo-
dates just four or five residues. In the VSV L-P complex, a tyrosine
side-chain packs against the base of the pocket; mutation of that
tyrosine to small residues severely impairs viral growth, but does
not affect RdRp activity (7). We have suggested that failure to
anchor P in that site may impede replication (but not transcrip-
tion) by interfering with efficient delivery of N to the product. That
function might explain the conservation of the position of the site,
but not its chemistry.
Priming for internal initiation and capping and priming for end
initiation may depend on different configurations and different
mechanisms for supporting the priming GTP. Internal initiation is
insensitive to mutation of Trp1180 (4), suggesting that the priming
loop remains retracted after termination of the leader transcript
and that support for the priming GTP comes from some other
source, such as the 3′ end of the preceding transcript, still base-
paired with the template (see a related, early proposal in ref. 34),
or from some aspect of the posttermination conformation of the
template-engaged RdRp domain. Each of the products of internal
initiation has a 5′-AACA sequence and forms a covalent attach-
ment with His1241. A noteworthy characteristic of the “closed”
initiation competent structure seen here and for VSV L is the
absence of an obvious GTP-binding site in the capping domain.
We suggest that the retracted priming loop and elongated nascent
transcript might create such a site, perhaps linked to the covalent
attachment of the 5′ end of the transcript to His1241. As long as
the 5′ attachment to His1241 is present, elongation will produce a
loop that will fill the CAP catalytic cavity and force the smaller do-
mains (CD, MT, CTD) to swing outward (SI Appendix, Fig. S14)—as
they do in the absence of P (Fig. 1). This transition to a more
open complex will allow GTP to diffuse into the CAP active-site
cavity (if it is not already there), and it will also expose the
methyltransferase catalytic site more completely than in the
closed structure. These steps may account for the observation that
capping of VSV mRNA occurs only after 31 nucleotides have
been transcribed (35).
The scheme proposed here provides a simple mechanism for
switching between replication mode, in which full-length product
acquires an N-protein coat, and transcription mode, in which an
mRNA product acquires a 5′ cap. It also provides an evolu-
tionary rationale for the distinctive capping mechanism (poly-
ribonucleotide transferase rather than guanylyl transferase)
found in NNS viruses. Retraction of the priming loop creates a
continuous cavity shared by the CAP and RdRp catalytic sites.
Covalent attachment of the 5′ end of the transcript then allows
ongoing RNA polymerization to fill this cavity with product
strand, generating the force needed to release the CD-MT-
CTD module. Tests of this model will require structures of
transcribing intermediates.
Materials and Methods
Protein Expression and Purification. We expressed 6xHis-tagged recombinant
RABV SAD-B19 L alone or with variants of RABV SAD-B19 P in SF9 or SF21
insect cells from baculovirus vectors constructed using the pFastBac-Dual re-
combination system (Thermo Fisher) as described previously (8). The N-terminal
fragments of RABV SAD-B19 P, P11–50, and P1–91 were expressed in Escherichia
coli and purified as previously described (8). The P variants GFP-P1–91, PFL, and
PΔOD with StrepII affinity tags were coexpressed with L in insect cells and
copurified with L. For GFP-P1–91, with an N-terminal StrepII tag, L-GFP-P1–91
complexes were purified first on nickel and then on Strep-Tactin resin (GE
Healthcare). For PFL, with a C-terminal StrepII tag, L-PFL complexes were puri-
fied first on Strep-Tactin and then on nickel resin. For PΔOD, with a hemag-
glutinin (HA) epitope tag followed by an internal HRV 3C protease cleavage
site in place of the deleted oligomerization domain of P (P residues 92 to 131),
as well as a C-terminal StrepII tag, L-PΔOD complexes were immobilized on
Strep-Tactin resin and then cleaved from the resin in the presence of HRV 3C
protease to yield purified complexes of L-P1–91. The nine-residue HA tag, not
used for purification, remained attached to P1–91 following proteolytic cleav-
age. For cryo-EM specimens, these L-PΔOD–derived L-P1–91 complexes were
further purified on a Superdex 200 Increase column, and the peak fractions
were concentrated to 0.3 mg/mL immediately before grid preparation. For
each grid, 3 μL of sample were applied to glow-discharged, C-Flat 400-mesh
copper grids coated with 40-nm-thick holey carbon (1.2/1.3 spacing) and
plunge-frozen in liquid ethane in a CP3 cryo-dipper.
Electron Microscopy. For the medium-resolution initial reconstruction, images
of RABV L-P1–91 were recorded on a Tecnai F20 electron microscope (FEI)
operated at 200 kV, using UCSF Image4 (Yuemin Li, University of California,
San Francisco) to collect movies on a K2 Summit direct detector (Gatan) in
superresolution mode with dose fractionation. For each 8-s exposure, we
collected 32 frames at 250 ms each with a total electron dose of 72 e/Å2.
Collection was performed at a nominal magnification of 29,000×, with a
calibrated pixel size of 1.28 Å/pixel. Movie frames were gain-subtracted,
Fourier-binned 2×, and motion-corrected using MotionCor2 with 5 × 5
patch correction.
For the high-resolution dataset, images were recorded on a Tecnai F30
Polara electron microscope (FEI) operated at 300 kV, using SerialEM to collect
movies on a K2 Summit direct detector (Gatan) in superresolution mode with
dose fractionation. For each 8-s exposure, we collected 32 frames at 250 ms
each with a total electron dose of 72 e/Å2. Collection was performed at a
nominal magnification of 31,000× with a calibrated physical pixel size of
1.234 Å/pixel.
Image Processing. Micrograph movie frames were gain-subtracted, Fourier-
binned to physical pixel size, and motion-corrected using MotionCor2 with
5 × 5 patch correction. Micrograph CTF coefficients were calculated using
CTFFIND4 (36), and particle images were CTF-corrected as needed by the
processing software used.
For the medium-resolution reconstruction, a single dataset was collected
from one of four identical grids prepared in parallel from a single protein
sample. We picked 43,000 particles by hand from 316 motion-corrected
movies using EMAN2.1 (37). A de novo 3D reference was obtained using
the ab-initio procedure in cisTEM (11) following preliminary 2D classification,
and the hand was subsequently flipped to yield a reference bearing strong
resemblance to VSV L-P. Final 2D and 3D classifications using the flipped
reference were then carried out in RELION 2.1 (38), yielding a 6.7 Å (medium-
resolution) map from 23,000 particles.



























































For the high-resolution reconstruction, we collected a total of 10,949 movies
from three datasets using the remaining three grids from the initial set of four.
Selected 20-Å low-pass-filtered projections of the 6.7-Å map were used as
particle-picking templates for autopicking in RELION (38). Autopicked particles
on each micrograph were manually cleaned of junk, contamination, noise,
drift, and otherwise bad or damaged particles using SamViewer, an interactive
image analysis program written in wxPython by Maofu Liao, Harvard Medical
School. From 5.3 M remaining particles, coarse 2D classification at a high-
resolution cutoff of 25 Å was performed in RELION (38) to remove addi-
tional poor particles, and classes representing dominant views were separated
from the remaining good classes, as described in SI Appendix, Fig. S2. Three-
dimensional classification was performed on 1.47 M nondominant view parti-
cles, and the best class of six was selected, containing 649 k particles. These
particles were added to the separated 408 k dominant view particles; a final
round of 3D classification then yielded a total of 963 k particles from the best
class of three. This particle set was then subjected to 3D refinement, per-
particle CTF refinement, and Bayesian polishing in RELION 3.0 (13), and the
resulting stack was imported into cisTEM (11) along with corresponding Euler
angles and offsets for further refinement, as described in SI Appendix, Figs. S1
and S2). The anisotropic 3D reconstruction from refinement in RELION 3.0 (13)
was used as a starting reference for manual refinement in cisTEM (11), and
particles were removed from the reconstruction at each refinement iteration
using the SCORE parameter. We quickly removed the worst-scoring 50% of
particles. Because dominant view particles had higher scores (due to anisotropy
of the map caused by a preferred orientation), we applied an angular binning
script to cap the number of particles per 4° × 4° bin, keeping those with the
highest scores. Further manual refinement using these remaining 177 k
particles with flattened angular distribution led to reduced anisotropy and
improved map quality, with the best 25% of particles by score giving the
highest-resolution map. A final refinement using this set of 44,500 particles
at an alignment resolution cutoff of 4.5 Å yielded a reasonably isotropic map
(despite a majority of particles having the preferred orientation) with an av-
erage resolution of 3.3 Å. The Electron Microscopy Data Bank (EMDB) accession
number for the deposited map is EMD-20753.
Model Building. To generate the atomicmodel of RABV L, we first replaced the
sequence of VSV L with RABV L in the model of VSV L (PDB ID 6U1X) (7),
adding simple loops where discontinuities in the alignment occurred. We fit
these coordinates as a single rigid body into the 3.3-Å RABV L-P1–91 density
map and then divided the coordinates into the five structural domains
(RdRp, CAP, CD, MT, and CTD) and refit each domain as a rigid body. We
then performed iterative real-space refinement using PHENIX (39, 40) at
increasing resolution, from 40 to 5 Å. The resulting model was then used as
an input model for ROSETTA (17). To improve loop fitting, we also input
libraries of 3- and 9-mer peptide structures corresponding to all 3- and 9-
amino acid sequences contained in the 2,127-residue RABV L sequence (41).
From 5,000 simulations, we selected a model with very good map-to-model
agreement and with visibly strong fitting of secondary structure elements
throughout. We then performed several rounds of manual adjustment in
Coot, alternating with real-space refinement in PHENIX, using secondary
structure restraints throughout and Ramachandran restraints in the final
rounds. The final model was validated using PHENIX and MolProbity (SI
Appendix, Table S1) and deposited in the Protein Data Bank under PDB
ID 6UEB.
Projection Matching. Molecules of RABV L in complex with GFP-P1–91 were
visualized by negative-stain EM at ∼0.01 mg/mL total protein in the presence
of 0.7% uranyl formate. Twenty-eight 2D class averages of picked particles
showed clear density for the GFP moiety at the N terminus of P (Fig. 4A and
SI Appendix, Figs. S5 and S6). We aligned the 2D class averages with obvious
GFP density to a single reference to standardize their orientation in the image
plane and applied a circular noise mask to obscure the GFP signal as much as
possible without obstructing signal from L. To determine the viewing angle of
the RABV L atomic model corresponding to each 2D class, we projected the
high-resolution RABV L-P1–91 cryo-EM map over all viewing angles, incre-
mented every ∼7.2° for a total of 800 projections. Projections were low-pass-
filtered to 20 Å and then scaled and clipped to match the pixel and box size of
the 2D classes, and a circular noise mask was applied to obscure the clipping
edges. Cross-correlation coefficients between projections and 2D classes were
obtained using e2simmx.py from EMAN2 (37), allowing for rotation and
translation only. The top projection match for each 2D class is shown in Fig. 4
and SI Appendix, Fig. S5, with GFP modeled as a best approximation.
L-PFL dimers, representing about 25% of L species on micrographs of neg-
atively stained, purified RABV L/PFL, were picked by hand and subjected to 2D
class averaging using EMAN2.1 (37). From 29 high-quality 2D class averages of
dimers, we extracted each of the 58 dimeric monomer averages as individual
particles (hereafter, DMAPs). We applied a circular noise mask to each DMAP
to obscure excess signal from the paired DMAPs present in each particle image.
We then projected the high-resolution RABV L-P1–91 cryo-EM map over all
viewing angles, incremented every ∼7.2° for a total of 800 projections. Pro-
jections were low-pass-filtered to 20 Å and then clipped and scaled to match
the box and pixel size of the negative-stain EM DMAPs, and a circular noise
mask was applied to obscure the clipping edges. Cross-correlation coefficients
between projections and DMAPs were obtained using e2simmx.py, allowing
for rotation and translation only. The resulting matrix was then normalized
within each DMAP over all projections, from which we constructed spherical
heat maps in the coordinate system of the RABV L-P1–91 cryo-EM map to fa-
cilitate visualization of peaks reflecting high cross-correlation scores. For about
half of the DMAPs, a single peak predominated, and application of the angular
coordinates from the peak to the atomic model of RABV L-P1–91 returned an
obvious match to the corresponding DMAP. Whenmore than one high-scoring
peak was observed, the best apparent visual match was selected. Of the 58
DMAP:projection comparisons, only 6 were matched to a secondary peak,
and 5 could not be reliably matched. In total, we successfully matched 24
of the 29 DMAP pairs. Using PyMOL (Schrödinger, LLC), we then applied
the angular coordinates from each match to an atomic model of RABV L-
P1–91 for each DMAP in a pair and approximated the relationship between
the two modeled DMAPs using only two dimensions (X and Y), as sug-
gested by the original 2D class average. We then measured the minimum
distance between C-alpha atoms of either P87 or the mapped, but un-
assigned, N-terminal-most residue of P in each modeled pair by translating
one of the models along the z axis. The results of these projection-
matching analyses are summarized in Fig. 4B and illustrated in detail in
SI Appendix, Fig. S8.
Visualization of Internal Cavities.We used the program VOIDOO (42) to probe
internal cavities, substrate entry, and product exit channels of the RABV
L-P1–91 complex. We used a probe radius of 1.8 Å to calculate a probe-occupied
volume.
Data Availability. Data for EM 3D reconstruction have been deposited in the
Electron Microscopy Data Bank (accession no. EMD-20753), and data for
coordinates fit to 3D reconstruction have been deposited in the Protein Data
Bank (PDB ID 6UEB).
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